explore | Grilled Cheese

@longevitytech.bsky.social Oct 15, 2026, 1:14 PM

Could GLP-1 drugs influence more than appetite? A 48-person trial found signals that semaglutide may affect alcohol consumption and cravings.

It’s early evidence, not an approved treatment. Read beyond the headline.

#longevity #geroscience #semaglutide

Text about a semaglutide trial with a glass and molecule graphic.

@vineturglobal.bsky.social Oct 14, 2026, 12:35 PM

Pittsburgh Researchers Plan a 1,200-Person Trial of Semaglutide for Alcohol and Opioid Addiction #Pittsburgh #Semaglutide #AddictionResearch #AlcoholAddiction #OpioidAddiction

@akerix-en.bsky.social Oct 10, 2026, 8:03 PM

Online semaglutide sales raise handling and dosing concerns in the Dominican Republic

#Akerix #AI #Semaglutide #DominicanRepublic
https://akerix.com/article/glp-1-health-risks?5w=1

@nile11.bsky.social Oct 10, 2026, 10:31 AM

U.S. Obesity Rate Drops as GLP-1 Drug Prices Plunge
..................
https://nile1.com/u-s-obesity-rate-drops-as-glp-1-drug-prices-plunge/
..................
#eliLilly #exenatide #fda #genericDrugs #gilaMonster #glp-1 #johnEng #novoNordisk #obesityRate #semaglutide #tirzepatide #type2Diabetes #weg

GettyImages-2280291370-e1791391498561-bit-social-bluesky-2000x2000.webp

@jamanetworkopen.com Oct 8, 2026, 4:51 AM

📈 Among US adults eligible for obesity treatment, oral #Semaglutide uptake increased rapidly after approval for #Obesity and approached injectable semaglutide within 3 months. More than half of initiators had no prior semaglutide use.

ja.ma/4j4VdN0

Line graph showing the incidence rate of new initiators per 10,000 OMM-eligible adults for three drugs (injectable tirzepatide, injectable semaglutide, oral semaglutide) from Dec 2025 to Mar 2026. Tirzepatide (green) is consistently highest, while oral semaglutide (blue) shows the steepest rise.

@breakingnews06.bsky.social Oct 6, 2026, 7:06 PM

Switching from GLP-1 Injections to Wegovy Pill Shows Additional Weight Loss of 4.1% #WeightLoss #Wegovy #GLP1 #Semaglutide #Obesity

@ismaileyesurgery.bsky.social Oct 6, 2026, 11:10 AM

@#Ozempic #Semaglutide #NAION #OpticNeuropathy #Ophthalmology

@thementalelf.bsky.social Oct 5, 2026, 6:41 AM

In a Swedish study of 95,490 people with depression or anxiety, semaglutide was linked to 42% lower risk of worsening of mental health problems, liraglutide 18%.

💊 Exenatide and dulaglutide: no link, so likely not a class effect.

buff.ly/19qrHQG

#Semaglutide #MentalHealth

@elitewomenscare.bsky.social Oct 3, 2026, 8:20 PM

✨ Medical Weight Loss Treatment at Elite Women’s Care ✨
Achieve sustainable weight loss under expert physician supervision with customized Semaglutide & Tirzepatide programs! 🌿
#WeightLoss #MedicalWeightLoss #Semaglutide #Tirzepatide #MedSpa #EliteWomensCare

@healthday.bsky.social Oct 2, 2026, 6:42 PM

GLP-1 use among new mothers rose 24-fold from 2018 to early 2025, as researchers caution that evidence on GLP-1 exposure during breastfeeding remains limited.
youtu.be/q_7pcsLTChs

#postpartumweightloss #postpartum #GLP1 #Ozempic #Zepbound #Mounjaro #Wegovy #Semaglutide #Tirzepatide

@midgardfinance.com Oct 2, 2026, 12:30 PM

💊 #pharma #EASD2026

🇺🇸 $LLY #orforglipron on major heart events vs insulin: hazard ratio 0.77 (0.52-1.13). Too small a trial to prove a benefit.

Not head to head: tirzepatide 0.92 vs dulaglutide; 🇩🇰 $NOVO #semaglutide pill 0.86, injection 0.80 vs placebo.

midgardfinance.com/cardiovascular/

Forest plot of hazard ratios for major heart events (heart attack, stroke or cardiovascular death) in four outcome trials of incretin drugs, on a log axis with a vertical line at 1; left of the line means fewer events than the comparison arm. The rows are in two groups because the trials were run against different things. Tested against placebo, in light blue: Semaglutide injection against placebo (SELECT, 17,604 patients): 0.80, interval 0.72 to 0.90. Semaglutide pill against placebo (SOUL, 9,650 patients): 0.86, interval 0.77 to 0.96. Tested against another drug, in purple: Tirzepatide against dulaglutide (SURPASS-CVOT, 13,299 patients): 0.92, interval 0.83 to 1.01. Orforglipron pill against insulin glargine (ACHIEVE-4, 2,749 patients): 0.77, interval 0.52 to 1.13. Orforglipron's estimate lies among the others, but its interval is about 4 times as wide and crosses 1: its trial was sized to rule out harm, which it did, not to prove a benefit. These are separate trials, not head-to-head comparisons. Dulaglutide is itself a heart-protective drug, so a ratio against it cannot be set beside a ratio against placebo, and SELECT enrolled people without diabetes while the other three enrolled people with type 2 diabetes. For orforglipron this is the three-part endpoint; its primary endpoint, which also counts hospitalisation for unstable angina, was 0.84 with an interval of 0.59 to 1.20.

@clinicalpainadv.bsky.social Oct 1, 2026, 4:09 PM

Adult patients prescribed #semaglutide for weight management demonstrated a sustained reduction in monthly triptan consumption compared with preinitiation trajectories. (@ehfofficial.bsky.social)

https://www.clinicalpainadvisor.com/news/semaglutide-weight-loss-reduced-triptan-use/

@sip-com-acpe.bsky.social Sep 30, 2026, 4:00 PM

Title: Weight-loss drug semaglutide alters reward-seeking behavior in healthy mice

Link: ift.tt/O4yaimK

#Semaglutide #Neuroscience #Psychotherapy #RewardProcessing #SpiritualityInTherapy

@enchantedhickie.bsky.social Sep 29, 2026, 8:03 PM

Metabolic-Psychiatric Connection:
GLP Meds Continue To Amaze 🔬
#Semaglutide #bipolar #depression #mentalillness

www.medscape.com/viewarticle/...

@newsen.bsky.social Sep 29, 2026, 10:18 AM

Ozempic® Found to Reduce Cardiovascular Risks in Diabetic Adults Compared to Mounjaro® #USA #Semaglutide #Plainsboro #Ozempic #Mounjaro

@jhepatology.bsky.social Sep 29, 2026, 7:06 AM

🆕 EASL-EASD-EASO guidance on resmetirom and semaglutide as #MASH-targeted therapy 💉#Semaglutide: preferred in patients with obesity, T2D or high cardiovascular risk 💊#Resmetirom: prioritised in those without obesity or unable to use GLP-1RAs 🔗https://bit.ly/4ynVQpR

@newsen.bsky.social Sep 29, 2026, 7:05 AM

Eli Lilly's Foundayo Outperforms Semaglutide in Weight Loss and A1C Reduction #USA #Indianapolis #Semaglutide #Eli_Lilly #Foundayo

@thelancetendo.bsky.social Sep 28, 2026, 2:16 PM

#Semaglutide was effective in decreasing #CKD progression regardless of the administration route or indication (type 2 #diabetes or #obesity), adding to the evidence provided by FLOW in people with type 2 diabetes & CKD www.thelancet.com/journals/lan...
#T2D

#MedSky #EndoSky #RenalSky #CardioSky

@newsmedical.bsky.social Sep 28, 2026, 3:43 AM

Semaglutide slashes major heart events by 20% - but science still can't fully explain why. Only a third of the benefit ties to known risk factors. What’s behind the rest? 🤔💉 #Semaglutide #HeartHealth
www.news-medical.net/news/2026092...

@nikolospharma.bsky.social Sep 26, 2026, 1:51 AM

#SaudiPharma #Semaglutide #PeptideAPI #SaudiArabia #KSA #PharmaSourcing #API #CDMO #PharmaSupplyChain